PFE logo

Pfizer (PFE) Accounts Payable

Annual Accounts Payable

$6.71 B
-$99.00 M-1.45%

31 December 2023

PFE Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$5.31 B
+$208.00 M+4.07%

30 September 2024

PFE Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PFE Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.4%-0.5%
3 y3 years+56.7%+13.1%
5 y5 years+43.6%+34.8%

PFE Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-1.4%+56.7%-22.0%+13.1%
5 y5 years-1.4%+72.6%-22.0%+37.2%
alltimeall time-1.4%+1571.7%-22.0%+1332.7%

Pfizer Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$5.31 B(+4.1%)
June 2024
-
$5.11 B(-8.7%)
Mar 2024
-
$5.59 B(-16.7%)
Dec 2023
$6.71 B(-1.5%)
$6.71 B(+25.7%)
Sept 2023
-
$5.34 B(-12.2%)
June 2023
-
$6.08 B(-0.7%)
Mar 2023
-
$6.12 B(-10.1%)
Dec 2022
$6.81 B(+22.1%)
$6.81 B(+8.6%)
Sept 2022
-
$6.27 B(+1.0%)
June 2022
-
$6.21 B(+12.7%)
Mar 2022
-
$5.51 B(-1.3%)
Dec 2021
$5.58 B(+30.2%)
$5.58 B(+18.7%)
Sept 2021
-
$4.70 B(+8.6%)
June 2021
-
$4.33 B(+6.5%)
Mar 2021
-
$4.06 B(-5.1%)
Dec 2020
$4.28 B(+10.2%)
$4.28 B(+3.4%)
Sept 2020
-
$4.14 B(+6.9%)
June 2020
-
$3.87 B(-2.5%)
Mar 2020
-
$3.97 B(+2.2%)
Dec 2019
$3.89 B(-16.8%)
$3.89 B(-1.4%)
Sept 2019
-
$3.94 B(-1.5%)
June 2019
-
$4.00 B(-3.7%)
Mar 2019
-
$4.16 B(-11.1%)
Dec 2018
$4.67 B(+0.4%)
$4.67 B(+8.8%)
Sept 2018
-
$4.30 B(+2.4%)
June 2018
-
$4.20 B(+8.2%)
Mar 2018
-
$3.88 B(-16.7%)
Dec 2017
$4.66 B(+2.6%)
$4.66 B(+33.8%)
Sept 2017
-
$3.48 B(+1.2%)
June 2017
-
$3.44 B(+1.4%)
Mar 2017
-
$3.39 B(-25.2%)
Dec 2016
$4.54 B(+25.3%)
$4.54 B(+30.5%)
Sept 2016
-
$3.48 B(+6.6%)
June 2016
-
$3.26 B(+4.4%)
Mar 2016
-
$3.13 B(-13.7%)
Dec 2015
$3.62 B(+12.8%)
$3.62 B(+9.9%)
Sept 2015
-
$3.29 B(+12.4%)
June 2015
-
$2.93 B(+7.6%)
Mar 2015
-
$2.72 B(-15.1%)
Dec 2014
$3.21 B(-0.7%)
$3.21 B(+8.0%)
Sept 2014
-
$2.97 B(-0.6%)
June 2014
-
$2.99 B(+17.4%)
Mar 2014
-
$2.55 B(-21.3%)
Dec 2013
$3.23 B(+10.7%)
$3.23 B(+41.4%)
Sept 2013
-
$2.29 B(+15.6%)
June 2013
-
$1.98 B(-39.7%)
Mar 2013
-
$3.28 B(+12.3%)
Dec 2012
$2.92 B(-20.6%)
$2.92 B(-1.6%)
Sept 2012
-
$2.97 B(-6.3%)
June 2012
-
$3.17 B(+2.4%)
Mar 2012
-
$3.09 B(-16.0%)
Dec 2011
$3.68 B(-8.6%)
$3.68 B(-2.3%)
Sept 2011
-
$3.77 B(+1.8%)
June 2011
-
$3.70 B(-1.4%)
Mar 2011
-
$3.75 B(-6.9%)
Dec 2010
$4.03 B(-7.9%)
$4.03 B(+25.6%)
Sept 2010
-
$3.21 B(+4.2%)
June 2010
-
$3.08 B(+1.7%)
Mar 2010
-
$3.03 B(-30.7%)
Dec 2009
$4.37 B(+149.6%)
$4.37 B(+76.1%)
Sept 2009
-
$2.48 B(-4.4%)
June 2009
-
$2.60 B(+65.0%)
Mar 2009
-
$1.57 B(-10.2%)
Dec 2008
$1.75 B(-22.9%)
$1.75 B(+6.2%)
Sept 2008
-
$1.65 B(-14.5%)
June 2008
-
$1.93 B(+1.0%)
Mar 2008
-
$1.91 B(-15.9%)
Dec 2007
$2.27 B
$2.27 B(-1.2%)
Sept 2007
-
$2.30 B(+24.6%)
June 2007
-
$1.84 B(-9.4%)
DateAnnualQuarterly
Mar 2007
-
$2.04 B(+0.9%)
Dec 2006
$2.02 B(-2.6%)
$2.02 B(+15.9%)
Sept 2006
-
$1.74 B(+0.1%)
June 2006
-
$1.74 B(-8.0%)
Mar 2006
-
$1.89 B(-8.7%)
Dec 2005
$2.07 B(-22.4%)
$2.07 B(+14.6%)
Sept 2005
-
$1.81 B(-13.9%)
June 2005
-
$2.10 B(-8.7%)
Mar 2005
-
$2.30 B(-13.9%)
Dec 2004
$2.67 B(+3.3%)
$2.67 B(+14.7%)
Sept 2004
-
$2.33 B(-6.1%)
June 2004
-
$2.48 B(+0.0%)
Mar 2004
-
$2.48 B(-4.2%)
Dec 2003
$2.59 B(+59.7%)
$2.59 B(+29.5%)
Sept 2003
-
$2.00 B(-5.8%)
June 2003
-
$2.12 B(+54.4%)
Mar 2003
-
$1.37 B(-15.2%)
Dec 2002
$1.62 B(+14.8%)
$1.62 B(+4.4%)
Sept 2002
-
$1.55 B(+1.8%)
June 2002
-
$1.52 B(-4.2%)
Mar 2002
-
$1.59 B(+12.8%)
Dec 2001
$1.41 B(-17.9%)
$1.41 B(-13.5%)
Sept 2001
-
$1.63 B(+5.8%)
June 2001
-
$1.54 B(+8.7%)
Mar 2001
-
$1.42 B(-17.5%)
Dec 2000
$1.72 B(-9.0%)
$1.72 B(+21.3%)
Sept 2000
-
$1.42 B(-1.6%)
June 2000
-
$1.44 B(+68.4%)
Mar 2000
-
$855.00 M(-54.7%)
Dec 1999
$1.89 B(+94.5%)
$1.89 B(+172.2%)
Sept 1999
-
$694.00 M(-9.9%)
June 1999
-
$770.00 M(+17.4%)
Mar 1999
-
$656.00 M(-32.4%)
Dec 1998
$971.00 M(+47.1%)
$971.00 M(+18.8%)
Sept 1998
-
$817.00 M(+0.4%)
June 1998
-
$814.00 M(+12.4%)
Mar 1998
-
$724.00 M(+9.7%)
Dec 1997
$660.00 M(-27.7%)
$660.00 M(-6.0%)
Sept 1997
-
$702.00 M(-27.7%)
June 1997
-
$971.00 M(+18.6%)
Mar 1997
-
$819.00 M(-10.3%)
Dec 1996
$913.00 M(+27.6%)
$913.00 M(+21.7%)
Sept 1996
-
$750.00 M(+15.0%)
June 1996
-
$652.00 M(+8.3%)
Mar 1996
-
$602.00 M(-15.8%)
Dec 1995
$715.30 M(+36.3%)
$715.30 M(+12.5%)
Sept 1995
-
$636.00 M(-11.1%)
June 1995
-
$715.10 M(+24.8%)
Mar 1995
-
$573.20 M(+9.2%)
Dec 1994
$524.90 M(+9.6%)
$524.90 M(+21.3%)
Sept 1994
-
$432.90 M(+1.4%)
June 1994
-
$427.10 M(-4.9%)
Mar 1994
-
$449.00 M(-6.3%)
Dec 1993
$479.10 M(+5.0%)
$479.10 M(+21.4%)
Sept 1993
-
$394.60 M(+2.7%)
June 1993
-
$384.30 M(+0.8%)
Mar 1993
-
$381.30 M(-16.5%)
Dec 1992
$456.40 M(-1.4%)
$456.40 M(+4.3%)
Sept 1992
-
$437.40 M(-2.0%)
June 1992
-
$446.10 M(+1.3%)
Mar 1992
-
$440.20 M(-4.9%)
Dec 1991
$462.90 M(+2.8%)
$462.90 M(+15.4%)
Sept 1991
-
$401.30 M(-2.4%)
June 1991
-
$411.00 M(-3.8%)
Mar 1991
-
$427.40 M(-5.1%)
Dec 1990
$450.30 M(+12.2%)
$450.30 M(+7.7%)
Sept 1990
-
$418.00 M(+10.3%)
June 1990
-
$379.00 M(+2.2%)
Mar 1990
-
$370.90 M(-7.6%)
Dec 1989
$401.40 M
$401.40 M

FAQ

  • What is Pfizer annual accounts payable?
  • What is the all time high annual accounts payable for Pfizer?
  • What is Pfizer annual accounts payable year-on-year change?
  • What is Pfizer quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Pfizer?
  • What is Pfizer quarterly accounts payable year-on-year change?

What is Pfizer annual accounts payable?

The current annual accounts payable of PFE is $6.71 B

What is the all time high annual accounts payable for Pfizer?

Pfizer all-time high annual accounts payable is $6.81 B

What is Pfizer annual accounts payable year-on-year change?

Over the past year, PFE annual accounts payable has changed by -$99.00 M (-1.45%)

What is Pfizer quarterly accounts payable?

The current quarterly accounts payable of PFE is $5.31 B

What is the all time high quarterly accounts payable for Pfizer?

Pfizer all-time high quarterly accounts payable is $6.81 B

What is Pfizer quarterly accounts payable year-on-year change?

Over the past year, PFE quarterly accounts payable has changed by -$24.00 M (-0.45%)